201 related articles for article (PubMed ID: 35791078)
1. The Probiotic Effects of the
Lee JE; Lee E
J Microbiol Biotechnol; 2022 Jul; 32(7):877-884. PubMed ID: 35791078
[TBL] [Abstract][Full Text] [Related]
2. Both
Xu X; Wu J; Jin Y; Huang K; Zhang Y; Liang Z
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986214
[TBL] [Abstract][Full Text] [Related]
3. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition.
Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J
J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870
[TBL] [Abstract][Full Text] [Related]
4. Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice.
Zhou H; Zhang HJ; Guan L; Zhang YN; Li Y; Sun MJ
Mol Med Rep; 2018 Dec; 18(6):5652-5662. PubMed ID: 30387820
[TBL] [Abstract][Full Text] [Related]
5. Probiotic potential of Saccharomyces cerevisiae GILA with alleviating intestinal inflammation in a dextran sulfate sodium induced colitis mouse model.
Kil BJ; Pyung YJ; Park H; Kang JW; Yun CH; Huh CS
Sci Rep; 2023 Apr; 13(1):6687. PubMed ID: 37095161
[TBL] [Abstract][Full Text] [Related]
6. Lactic Acid-Producing Probiotic
Sun S; Xu X; Liang L; Wang X; Bai X; Zhu L; He Q; Liang H; Xin X; Wang L; Lou C; Cao X; Chen X; Li B; Wang B; Zhao J
Front Immunol; 2021; 12():777665. PubMed ID: 34899735
[TBL] [Abstract][Full Text] [Related]
7. Anti-Inflammatory, Barrier Maintenance, and Gut Microbiome Modulation Effects of
Hu Q; Yu L; Zhai Q; Zhao J; Tian F
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047694
[TBL] [Abstract][Full Text] [Related]
8. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide.
Liu CH; Chang JH; Chang YC; Mou KY
J Mol Med (Berl); 2020 Dec; 98(12):1675-1687. PubMed ID: 33025105
[TBL] [Abstract][Full Text] [Related]
9. Strain-Specific Anti-inflammatory Properties of Two
Zhai R; Xue X; Zhang L; Yang X; Zhao L; Zhang C
Front Cell Infect Microbiol; 2019; 9():239. PubMed ID: 31334133
[No Abstract] [Full Text] [Related]
10. A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii.
Garrido-Mesa J; Algieri F; Rodriguez-Nogales A; Utrilla MP; Rodriguez-Cabezas ME; Zarzuelo A; Ocete MA; Garrido-Mesa N; Galvez J
Pharmacol Res; 2015 Jul; 97():48-63. PubMed ID: 25917208
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice.
Dong JP; Zheng Y; Wu T; He Q; Teng GG; Wang HH
Chin Med J (Engl); 2019 Aug; 132(16):1951-1958. PubMed ID: 31335471
[TBL] [Abstract][Full Text] [Related]
12. Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation.
Chen X; Yang G; Song JH; Xu H; Li D; Goldsmith J; Zeng H; Parsons-Wingerter PA; Reinecker HC; Kelly CP
PLoS One; 2013; 8(5):e64227. PubMed ID: 23675530
[TBL] [Abstract][Full Text] [Related]
13.
Gao H; Li Y; Sun J; Xu H; Wang M; Zuo X; Fu Q; Guo Y; Chen Z; Zhang P; Li X; Wang N; Ye T; Yao Y
Oxid Med Cell Longev; 2021; 2021():1622375. PubMed ID: 34367460
[No Abstract] [Full Text] [Related]
14. Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate.
Nanda Kumar NS; Balamurugan R; Jayakanthan K; Pulimood A; Pugazhendhi S; Ramakrishna BS
J Gastroenterol Hepatol; 2008 Dec; 23(12):1834-9. PubMed ID: 19120873
[TBL] [Abstract][Full Text] [Related]
15. Ameliorative Effect of
Zeng X; Li X; Yue Y; Wang X; Chen H; Gu Y; Jia H; He Y; Yuan Y; Yue T
J Agric Food Chem; 2022 Nov; 70(44):14179-14192. PubMed ID: 36260319
[TBL] [Abstract][Full Text] [Related]
16. Anti-Inflammatory and Gut Microbiota Modulating Effects of Probiotic
Ladda B; Jantararussamee C; Pradidarcheep W; Kasorn A; Matsathit U; Taweechotipatr M
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986118
[TBL] [Abstract][Full Text] [Related]
17. Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics.
Celiberto LS; Pinto RA; Rossi EA; Vallance BA; Cavallini DCU
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400640
[TBL] [Abstract][Full Text] [Related]
18. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.
Mennigen R; Nolte K; Rijcken E; Utech M; Loeffler B; Senninger N; Bruewer M
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1140-9. PubMed ID: 19221015
[TBL] [Abstract][Full Text] [Related]
19. The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice.
Garrido-Mesa N; Utrilla P; Comalada M; Zorrilla P; Garrido-Mesa J; Zarzuelo A; Rodríguez-Cabezas ME; Gálvez J
Biochem Pharmacol; 2011 Dec; 82(12):1891-900. PubMed ID: 21930116
[TBL] [Abstract][Full Text] [Related]
20. Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis.
Jawhara S; Poulain D
Med Mycol; 2007 Dec; 45(8):691-700. PubMed ID: 17885943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
